Aquaporins (AQPs) are membrane water channels expressed in many mammalian tissues that carry out fluid transport. This competitive renewal builds on our discoveries of three novel, unanticipated AQP functions - cell migration, cell proliferation and neuroexcitation - each with the potential to yield new therapies for human diseases. The proposed studies utilize cell and mouse models of AQP gene deletion, knockdown and overexpression, and state-of-the-art biophysical methods.
Aim 1 will elucidate cellular mechanisms of AQP-facilitated cell migration. Biophysical studies will be done to test the hypothesis that AQP expression in membrane protrusions in migrating cells facilitates water influx and lamellipodial dynamics.
Aim 2 will elucidate cellular mechanisms of AQP3-facilitated cell proliferation. The hypothesis will be tested that AQP3-faciliated glycerol transport alters cellular glycerol metabolism, which is a key determinant of cellular ATP/energetics, MAPK signaling and biosynthesis.
Aim 3 will elucidate the cellular mechanisms by which AQP4 facilitates the neurotransmission function of electrically excitable cells. Biophysical methods, including novel K+-sensitive fluorescent indicators developed by our lab, will be used to test our working hypothesis that AQP4 expression facilitates K+ reuptake by glial cells following neuroexcitation by an indirect osmotic mechanism involving solute-solvent coupling. In addition to establishing new paradigms on the physiological functions of AQPs, the proposed research will provide a rational basis for identification of AQP modulators for tumor therapy, accelerating wound repair, and medical management of epilepsy.
The aquaporins are a family of membrane transporters of water and glycerol. This proposal will establish cellular mechanisms by which aquaporins are involved in cell migration, cell proliferation and neuroexcitation. The outcomes of this research will include improved understanding and potential new therapies for tumors, wound healing and epilepsy.
|Phuan, Puay-Wah; Veit, Guido; Tan, Joseph et al. (2014) Synergy-based small-molecule screen using a human lung epithelial cell line yields ?F508-CFTR correctors that augment VX-809 maximal efficacy. Mol Pharmacol 86:42-51|
|Zhang, Hua; Verkman, A S (2014) Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59. J Autoimmun 53:67-77|
|Esteva-Font, Cristina; Jin, Byung-Ju; Verkman, A S (2014) Aquaporin-1 gene deletion reduces breast tumor growth and lung metastasis in tumor-producing MMTV-PyVT mice. FASEB J 28:1446-53|
|Asavapanumas, Nithi; Ratelade, Julien; Papadopoulos, Marios C et al. (2014) Experimental mouse model of optic neuritis with inflammatory demyelination produced by passive transfer of neuromyelitis optica-immunoglobulin G. J Neuroinflammation 11:16|
|Tradtrantip, Lukmanee; Ko, Eun-A; Verkman, Alan S (2014) Antidiarrheal efficacy and cellular mechanisms of a Thai herbal remedy. PLoS Negl Trop Dis 8:e2674|
|Katada, Ryuichi; Akdemir, Gokhan; Asavapanumas, Nithi et al. (2014) Greatly improved survival and neuroprotection in aquaporin-4-knockout mice following global cerebral ischemia. FASEB J 28:705-14|
|Asavapanumas, Nithi; Verkman, A S (2014) Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury. Acta Neuropathol Commun 2:48|
|Akdemir, Gökhan; Ratelade, Julien; Asavapanumas, Nithi et al. (2014) Neuroprotective effect of aquaporin-4 deficiency in a mouse model of severe global cerebral ischemia produced by transient 4-vessel occlusion. Neurosci Lett 574:70-5|
|Smith, Alex J; Jin, Byung-Ju; Ratelade, Julien et al. (2014) Aggregation state determines the localization and function of M1- and M23-aquaporin-4 in astrocytes. J Cell Biol 204:559-73|
|Ratelade, Julien; Smith, Alex J; Verkman, A S (2014) Human immunoglobulin G reduces the pathogenicity of aquaporin-4 autoantibodies in neuromyelitis optica. Exp Neurol 255:145-53|
Showing the most recent 10 out of 367 publications